Circulation, Vol 61, 549-554, Copyright © 1980 by American Heart Association
MH Crawford, J Lindenfeld and RA O'Rourke
Oral propranolol (160 mg/day) was administered to 19 normal subjects for 2
weeks. Echocardiograms were performed at rest, during graded supine bicycle
exercise in 10 subjects and during acute pressure loading with intravenous
phenylephrine in the remaining nine subjects. Resting heart rate on
propranolol decreased compared with control (52 +/- 8 vs 63 +/- 10
beats/min; p less than 0.001), as did systolic blood pressure (99 +/- 9 vs
107 +/- 9 mm Hg; p less than 0.01). Left ventricular end-diastolic
dimension was slightly enlarged (48.3 +/- 4.2 vs 47.1 +/- 3.6 mm, p =
0.05), but percent dimensional shortening was unchanged (37 +/- 4 vs 38 +/-
5%). At each stage during supine bicycle exercise, heart rate was slower,
blood pressure lower, left ventricular dimensions were larger and percent
dimensional shortening was reduced on propranolol by an analysis of
variance. In contrast, during acute pressure loading, while the heart rate
response to increased blood pressure was blocked by atropine, there was no
significant difference in left ventricle size and performance compared with
control. We conclude that prolonged oral propranolol therapy has little, if
any, intrinsic effect on myocardial performance in normal subjects. Its
major action on the heart is competitive inhibition of beta-adrenergic
tone, which is most manifest during conditions associated with increased
sympathetic tone, such as exercise.
ARTICLES
Effects of oral propranolol on left ventricular size and performance during exercise and acute pressure loading
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1980 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |